Cargando…

Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms

BACKGROUND: Parkinson’s disease (PD) and atypical parkinsonisms (APD) have overlapping symptoms challenging an early diagnosis. Diagnostic accuracy is important because PD and APD have different prognosis and response to treatment. We aimed to identify diagnostic inflammatory biomarkers of PD and AP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santaella, Anna, Kuiperij, H. Bea, van Rumund, Anouke, Esselink, Rianne A. J., van Gool, Alain J., Bloem, Bastiaan R., Verbeek, Marcel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6967088/ https://www.ncbi.nlm.nih.gov/pubmed/31952511 http://dx.doi.org/10.1186/s12883-020-1608-8

Ejemplares similares

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
por: Marques, Tainá M., et al.
Publicado: (2016)

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Marques, Tainá M., et al.
Publicado: (2021)

Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls
por: Marques, Tainá M., et al.
Publicado: (2018)

Factors associated with mortality in early stages of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2022)

Parkinson’s Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2018)

α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2019)

Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson’s Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study
por: Meijer, Frederick J.A., et al.
Publicado: (2016)

Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism
por: Meijer, Frederick J. A., et al.
Publicado: (2015)

Proteomic profiling of striatal tissue of a rat model of Parkinson's disease after implantation of collagen‐encapsulated human umbilical cord mesenchymal stem cells
por: Santaella, Anna, et al.
Publicado: (2020)

Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
por: van Rumund, Anouke, et al.
Publicado: (2021)

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders
por: Herbert, Megan K., et al.
Publicado: (2015)

Trait Impulsivity Is Associated with the Risk of Falls in Parkinson’s Disease
por: Smulders, Katrijn, et al.
Publicado: (2014)

Clinical Application of Brain MRI in the Diagnostic Work-up of Parkinsonism
por: Meijer, Frederick J.A., et al.
Publicado: (2017)

Mechanisms of peripheral levodopa resistance in Parkinson’s disease
por: Beckers, Milan, et al.
Publicado: (2022)

Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
por: Smulders, Katrijn, et al.
Publicado: (2012)

Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐Analysis
por: Nijhuis, Frouke A.P., et al.
Publicado: (2021)

Gender Distribution in Deep Brain Stimulation for Parkinson’s Disease: The Effect of Awake versus Asleep Surgery
por: Vinke, R. Saman, et al.
Publicado: (2022)

A LRSAM1 mutation links Charcot–Marie–Tooth type 2 to Parkinson's disease
por: Aerts, Marjolein B., et al.
Publicado: (2015)

The Role of Microelectrode Recording in Deep Brain Stimulation Surgery for Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Vinke, R. Saman, et al.
Publicado: (2022)

Contribution of routine brain MRI to the differential diagnosis of parkinsonism: a 3-year prospective follow-up study
por: Meijer, Frederick J. A., et al.
Publicado: (2011)

People with Parkinson’s as Partners for the Journal of Parkinson’s Disease
por: McFarthing, Kevin, et al.
Publicado: (2023)

Enhanced motivation of cognitive control in Parkinson's disease
por: Timmer, Monique H.M., et al.
Publicado: (2018)

Parkinson’s Disease: We Care!
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

The state of telemedicine for persons with Parkinson's disease
por: van den Bergh, Robin, et al.
Publicado: (2021)

Prospective assessment of subjective sleep benefit in Parkinson’s disease
por: van Gilst, Merel M, et al.
Publicado: (2015)

The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease
por: Bloem, B. R., et al.
Publicado: (2019)

Inhibition of Neuroinflammation May Mediate the Disease-Modifying Effects of Exercise: Implications for Parkinson’s Disease
por: Darweesh, Sirwan K.L., et al.
Publicado: (2022)

Hopamine as Personalized Medicine for Persons with Parkinson’s Disease
por: Noordegraaf, Marina A., et al.
Publicado: (2023)

Pulsatile Proptosis due to Intraorbital Meningocele
por: van Rumund, Anouke, et al.
Publicado: (2017)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
por: Lin, Chin-Hsien, et al.
Publicado: (2018)

The Journal of Parkinson’s Disease Takes the Open Road
por: Bloem, Bastiaan R., et al.
Publicado: (2023)

Biphasic Levodopa-Induced Freezing of Gait in Parkinson’s Disease
por: Nonnekes, Jorik, et al.
Publicado: (2020)

The Clinical Evaluation of Parkinson’s Tremor
por: Zach, Heidemarie, et al.
Publicado: (2015)

The Emerging Evidence of the Parkinson Pandemic
por: Dorsey, E. Ray, et al.
Publicado: (2018)

MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid
por: Müller, Mareike, et al.
Publicado: (2015)

Neurovestibular Dysfunction and Falls in Parkinson's Disease and Atypical Parkinsonism: A Prospective 1 Year Follow-Up Study
por: Venhovens, Jeroen, et al.
Publicado: (2020)

The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease
por: Vinke, R. Saman, et al.
Publicado: (2022)

Addressing the “Replication Crisis” in the Field of Parkinson’s Disease
por: Albanese, Federica, et al.
Publicado: (2023)

A Positive ‘Pointing Test’ in a Parkinson’s Disease Patient
por: Zach, Heidemarie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u6v9vc8kpr464oeod1fsubdig7